Loddenkemper Christoph, Schernus Martin, Noutsias Michel, Stein Harald, Thiel Eckhard, Nagorsen Dirk
Department of Pathology, Charité -Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany.
J Transl Med. 2006 Dec 13;4:52. doi: 10.1186/1479-5876-4-52.
The immune system spontaneously responds to tumor-associated antigens in peripheral blood of colorectal cancer (CRC) patients. Regulatory T cells (Treg) are suspected of influencing the interaction between the tumor and immune system and thus the course of malignant diseases. However, the function of Tregs in the development of T cell responses and on the clinical course of CRC is not clear. We analyzed Treg infiltration (FOXP3 staining) in situ in 40 CRC patients and investigated whether there is a correlation to disease stage, systemic T cell response, and survival. Treg infiltration was significantly higher in CRC than in healthy colon. Stromal Treg infiltration was significantly higher than epithelial infiltration in CRC. Furthermore, Treg infiltration in the tumor was significantly higher in limited disease than in metastatic CRC. The average Treg infiltration rate in the tumor was non-significantly higher in patients without systemic TAA-specific T cell response. Survival did not differ between patients with high Treg infiltration and those with low Treg infiltration. In conclusion, a direct link between Treg infiltration in the tumor and the development of a systemic T cell response in CRC cannot be proven. However, local Treg infiltration was significantly higher in limited disease, in which a systemic TAA-directed T cell responses is less frequently observed.
免疫系统会对结直肠癌(CRC)患者外周血中的肿瘤相关抗原产生自发反应。调节性T细胞(Treg)被怀疑会影响肿瘤与免疫系统之间的相互作用,进而影响恶性疾病的进程。然而,Treg在T细胞反应发展及CRC临床进程中的作用尚不清楚。我们分析了40例CRC患者原位Treg浸润情况(FOXP3染色),并研究其与疾病分期、全身T细胞反应及生存率是否相关。CRC中Treg浸润显著高于健康结肠。CRC中基质Treg浸润显著高于上皮浸润。此外,局限性疾病中肿瘤内Treg浸润显著高于转移性CRC。无全身肿瘤相关抗原(TAA)特异性T细胞反应的患者肿瘤内平均Treg浸润率略高,但无统计学意义。Treg浸润高的患者与Treg浸润低的患者生存率无差异。总之,无法证明肿瘤内Treg浸润与CRC全身T细胞反应发展之间存在直接联系。然而,在局限性疾病中局部Treg浸润显著更高,而局限性疾病中较少观察到全身TAA定向T细胞反应。